Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines
Delivery carriers are a critical component in the development of mRNA vaccines. Here, we describe the synthesis of a cationic polymer as a carrier for mRNA cancer vaccine delivery. In vivo results show that this polymer-based mRNA vaccine significantly delays tumor growth after vaccination of mice.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743697/
Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccine-CEJ 2023 Jan
Related Content
From April 25 to 30, 2025, the annual meeting of the American Association for Cancer Research (AACR), one of the...
VIEW RESOURCEAt this year’s annual meeting of the American Association for Cancer Research (AACR), WuXi Biology has been selected to present...
VIEW RESOURCE